Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome

Lupus

Volumn 8, Issue 9, 1999, Pages 761-766

  Akimoto, T ^a   Akama, T ^a   Kono, I ^b   Sumida, T ^a,c  

^a University of Tsukuba   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Prothrombin; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; EPITOPE; LUPUS ANTICOAGULANT; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0032704060     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678840963     Document Type: Article

References (25)

1. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996; 39: 1444-1454.
2. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-462.
3. 2-glycoprotein I in the absence of phospholipid. J Immunol 1995; 154: 954-960.
4. Loeliger A. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?. Thromb Diath Haemorrh 1959; 3: 237-256.
5. Arvieux J, Darnige L, Caron C et al. Development of an ELlSA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125.
6. Bevers EM, Galli M, Barbui T et al. Lupus anticoagulant IgG's(LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
7. Rao LV, Hoang AD, Rapaport S. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood 1996; 88: 4173-4182.
8. Cote HC, Huntsman DG, Wu J et al. A new method for characterization and epitope determination of a lupus anticoagulant-associated neutralizing antiprothrombin antibody. Am J Pathol 1997; 107: 196-204.
9. Horbach DA, Oort Ev, Derksen RHWM, de Groot PG. The contribution of anti-prothrombin-antibodies to lupus anticoagulant activity. Thromb Haemost 1998; 79: 790-795.
10. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-1277.
11. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-326.
12. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant. Thromb Haemost 1994; 74: 1185-1190.
13. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993; 70: 787-793.
14. Akimoto T, Akama T, Kono I et al. Detergent and antigen fragility affect the ELISA for measurement of anti-prothrombin autoantibodies. J Rheumatol 1999; 26: 580-587.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
16. Bradford MM. A rapid and sensitive method of the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
17. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994; 83: 2878-2892.
18. Rao LV, Hoang AD, Rapaport S. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thromb Haemost 1995; 73: 668-674.
19. Galli M, Beretta G, Daldossi M et al. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997; 77: 486-491.
20. Bajaj SP, Butkowski RJ, Mann KG. Prothrombin fragments. Ca2+ binding and activation kinetics. J Biol Chem 1975; 250: 2150-2156.
21. Malia RG, Brookfield C, Bulman L, Greaves M. Prothrombin fragment F1-2; the epitope for antiphospholipid antibody expression. Thromb Haemost 1997; 71: s170.
22. 2GPI binding to phospholipids. J Clin Invest 1997; 99: 2260-2268.
23. de Groot PG, Horbach DA, Simmelink KJA et al. Anti-prothrombin antibodies and their relation with thrombin and lupus anticoagulant. Lupus 1998; 7: s32-s36.
24. Bajaj SP, Rapaport SI, Fierer DS et al. A mechanisms for the hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-692.
25. Bajaj SP, Rapaport SI, Barclay S, Herbst KD. Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management. Blood 1985; 65: 1538-1543.